Insulin was found to stimulate insulin–IGF-1 signaling in tumor cells and result in an activation of the oncogenic Ras–MAPK and PI3K–Akt pathways (MAPK = mitogen-activated protein kinase, PI3K = phosphoinositide 3-kinase), which subsequently stimulate tumor cell growth [29]. The gene discussed is IGF1; the disease is neoplasm.